SCHEMBL3207160

SCHEMBL3207160

Cn1nnc(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)Cc2cc(C(F)(F)F)cnc2C(=O)NC2CCCCC2)n1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CETP P11597 18/20 0.39
TACR1 P25103 1/20 0.38
CRHR1 P34998 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207206 0.89 GLS (0.43) CETP
SCHEMBL3221198 0.88 CETP (0.41) CETPTACR1
SCHEMBL3198681 0.86 CETP (0.39) CETP
SCHEMBL13491317 0.86 CETP (0.39) CETP
SCHEMBL3205200 0.84 SGMS2 (0.40) CETPTACR1
SCHEMBL3209856 0.84 CETP (0.38) CETP
SCHEMBL13491322 0.84 CETP (0.38) CETP
SCHEMBL3217676 0.84 CETP (0.40) CETPTACR1
SCHEMBL3225149 0.83 CETP (0.40) CETP
SCHEMBL3201375 0.83 CETP (0.41) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041705-A1 Organic Compounds NOVARTIS AG 2010-02-18 US disclosed
US-20100041705-A1 Organic Compounds NOVARTIS AG 2010-02-18 US disclosed
US-20100041705-A1 Organic Compounds NOVARTIS AG 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041705-A1 Organic Compounds CETP, NPC1, LCAT CETP 1/4885TACR1 1439/4885CRHR1 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.